Is early postpartum HbA1c an appropriate risk predictor after pregnancy with gestational diabetes mellitus?

Acta Diabetologica

Volumn 51, Issue 5, 2014, Pages 715-722

  Göbl, Christian S ^a   Bozkurt, Latife ^a   Yarragudi, Rajashri ^a   Tura, Andrea ^b   Pacini, Giovanni ^b   Kautzky Willer, Alexandra ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b CNR   (Italy)

Author keywords

Gestational diabetes mellitus; HbA1c; Impaired fasting glucose; Impaired glucose tolerance; Oral glucose tolerance test; Postpartum risk stratification

Indexed keywords

C PEPTIDE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN;

ADULT; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; DISORDERS OF CARBOHYDRATE METABOLISM; EARLY DIAGNOSIS; ENDOCRINE FUNCTION; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; GLUCOSE DISPOSITION INDEX; HEMOGLOBIN BLOOD LEVEL; HIGH RISK PREGNANCY; HUMAN; IMPAIRED FASTING GLUCOSE; IMPAIRED GLUCOSE TOLERANCE; INSULIN SENSITIVITY; INTRAVENOUS GLUCOSE TOLERANCE TEST; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; ORAL GLUCOSE TOLERANCE TEST; PREDICTION; PREDICTOR VARIABLE; PREGNANCY DIABETES MELLITUS; PUERPERIUM; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; BLOOD; DIAGNOSTIC USE; METABOLISM; PREGNANCY;

ADULT; BLOOD GLUCOSE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; DIABETES, GESTATIONAL; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LONGITUDINAL STUDIES; POSTPARTUM PERIOD; PREGNANCY;

EID: 84919474789     PISSN: 09405429     EISSN: 14325233     Source Type: Journal    
DOI: 10.1007/s00592-014-0574-2     Document Type: Article

References (39)

1. Bellamy L, Casas JP, Hingorani AD, Williams D (2009) Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta analysis. Lancet 373:1773–1779
2. International Association of Diabetes and Pregnancy Study Groups Consensus Panel (2010) International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 33:676–682
3. Abdul-Ghani MA, Tripathy D, DeFronzo RA (2006) Contributions of β-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose. Diabetes Care 29:1130–1139
4. Abdul-Ghani MA, DeFronzo RA (2009) Plasma glucose concentration and prediction of future risk of type 2 diabetes. Diabetes Care 32:S194–S198
5. Tabak AG, Herder C, Rathmann W, Brunner EJ, Kivimäki M (2012) Prediabetes a high-risk state for diabetes development. Lancet 379:2279–2290
6. Ratner RE, Christophi CA, Metzger BE, Dabelea D, Bennett PH, Pi-Sunyer X, Fowler S, Kahn SE, Diabetes Prevention Program Research Group (2008) Prevention of diabetes in women with a history of gestational diabetes: effects of metformin and lifestyle interventions. J Clin Endocrin Metab 93:4774–4779
7. American Diabetes Association (2010) Standards of medical care in diabetes—2010. Diabetes Care 33:S11–S61
8. World Health Organisation (2011) Use of glycated haemoglobin (HbA1c) in the diagnosis of diabetes mellitus. World health Organisation, Geneva
9. The International Expert Committee (2009) International expert committee report on the role of the A1C Assay in the diagnosis of diabetes. Diabetes Care 32:1327–1334
10. Cohen RM, Haggerty S, Herman WH (2010) HbA1c for the diagnosis of diabetes and prediabetes: is it time for a mid-course correction? J Clin Endocrinol Metab 95:5203–5206
11. Kim C, Herman WH, Cheung NW, Gunderson EP, Richardson C (2011) Comparison of haemoglobin A1c with fasting plasma glucose and 2-h postchallenge glucose for risk stratification among women with recent gestational diabetes mellitus. Diabetes Care 34:1949–1951
12. Picon MJ, Murri M, Munoz A, Fernandez-Garcia JC, Gomez-Huelgas R, Tinahones FJ (2012) Hemoglobin A1c versus oral glucose tolerance test in postpartum screening. Diabetes Care 35:1648–1653
13. Winzer C, Wagner O, Festa A, Schneider B, Roden M, Bancher-Todesca D, Pacini G, Funahashi T, Kautzky-Willer A (2004) Plasma adiponectin, insulin sensitivity, and subclinical inflammation in women with prior gestational diabetes mellitus. Diabetes Care 27:1721–1727
14. Metzger BE, Coustan DR (1998) The organizing committee: summary and recommendations of the fourth international workshop-conference on gestational diabetes mellitus. Diabetes Care 21(2):161–167
15. Pacini G, Tonolo G, Sambataro M, Maioli M, Ciccarese M, Brocco E, Avogaro A, Nosadini R (1998) Insulin sensitivity and glucose effectiveness: minimal model analysis of regular and insulin-modified FSIGT. Am J Physiol Endocrinol Metab 274:E592–E599
16. Kahn SE, Prigeon RL, McCulloch DSK (2002) Quantification of the relationship between insulin sensitivity and β-cell function in human subjects: evidence for a hyperbolic function. Diabetes 42:1663–1672
17. Mari A, Pacini G, Murphy E, Ludvik B, Nolan JJ (2001) A model based method for assessing insulin sensitivity from the oral glucose tolerance test. Diabetes Care 24:539–548
18. Tura A, Kautzky-Willer A, Pacini G (2006) Insulinogenic indices from insulin and C-peptide:comparison of beta-cell function from OGTT and IVGTT. Diabetes Res Clin Pract 72:298–301
19. Göbl CS, Bozkurt L, Prikoszovich T, Winzer C, Pacini G, Kautzky-Willer A (2011) Early possible risk factors for overt diabetes after gestational diabetes mellitus. Obstet Gynecol 118:71–78
20. Bozkurt L, Göbl CS, Tura A, Chmelik M, Prikoszovich T, Kosi L, Wagner O, Roden M, Pacini G, Gastaldelli A, Kautzky-Willer A (2012) Fatty liver index predicts further metabolic deteriorations in women with previous gestational diabetes. PLoS ONE 7:e32710
21. Tura A, Grassi A, Winhofer Y, Guolo A, Pacini G, Mari A, Kautzky-Willer A (2012) Progression to type 2 diabetes in women with former gestational diabetes: time trajectories of metabolic parameters. PLoS ONE 7:e50419
22. Göbl CS, Bozkurt L, Prikoszovich T, Tura A, Pacini G, Kautzky-Willer A (2013) Estimating the risk after gestational diabetes mellitus: can we improve the information of the postpartum OGTT? Am J Physiol Endocrinol Metab 304:E524–E530
23. Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez JC, Müller M (2011) pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinform 7:77. doi:10.1186/1471-2105-12-77
24. R Core Team (2013). R: a language and environment for statistical computing. R Foundation for Statistical Computing. http://www.R-project.org/ 6 June 2013
25. Lorenzo C, Wagenknecht LE, Hanley AJ, Rewers MJ, Karter AJ, Haffner SM (2010) A1C between 5.7 and 6.4 % as a marker for identifying pre-diabetes, insulin sensitivity and secretion, and cardiovascular risk factors: the Insulin Resistance and Atherosclerosis Study (IRAS). Diabetes Care 33:2104–2109
26. Kanat M, Winnier D, Norton L, Arar N, Jenkinson C, DeFronzo RA, Abdul-Ghani MA (2011) The relationship between β-cell function and glycated hemoglobin: results from the veterans administration genetic epidemiology study. Diabetes Care 34:1006–1010
27. Bianchi C, Miccoli R, Bonadonna RC, Giorgino F, Frontoni S, Faloia E, Marchesini G, Dolci MA, Cavalot F, Cavallo GM, Leonetti F, Del Prato S, GENFIEV Investigators (2012) Pathogenetic mechanisms and cardiovascular risk: differences between HbA(1c) and oral glucose tolerance test for the diagnosis of glucose tolerance. Diabetes Care 35:2607–2612
28. Ahrén B, Pacini G (2004) Importance of quantifying insulin secretion in relation to insulin sensitivity to accurate assess beta cell function in clinical studies. Eur J Endocrinol 150:97–104
29. Kautzky-Willer A, Handisurya A (2009) Metabolic diseases and associated complications: sex and gender matter! Eur J Clin Invest 39:631–648
30. Morris DH, Khunti K, Achana F, Srinivasan B, Gray LJ, Davies MJ, Webb D (2013) Progression rates from HbA1c 6.0–6.4% and other prediabetes definitions to type 2 diabetes: a meta analysis. Diabetologia 56:1489–1493
31. Mann DM, Carson AP, Shimbo D, Fonseca V, Fox CS, Mutner P (2010) Impact of A1C screening criterion on the diagnosis of pre-diabetes among U.S. adults. Diabetes Care 33:2190–2195
32. James C, Bullard KM, Rolka DB, Geiss LS, Williams DE, Cowie CC, Albright A, Gregg EW (2011) Implications of alternative definitions of prediabetes for prevalence in U.S. adults. Diabetes Care 34:387–391
33. Lapolla A, Mosca A, Fedele D (2011) The general use of glycated haemoglobin for the diagnosis of diabetes and other categories of glucose intolerance: still a long way to go. Nutr Metab Cardiovasc Dis 21:467–475
34. Seals DR, Hagberg JM, Allen WK, Hurley BF, Dalsky GP, Ehsani AA, Holloszy JO (1984) Glucose tolerance in young and older athletes and sedentary men. J Appl Physiol 56:1521–1525
35. Herman WH, Ma Y, Uwaifo G, Haffner S, Kahn SE, Horton ES, Lachin JM, Montez MG, Brenneman T, Barrett-Connor E (2007) Differences in A1C by race and ethnicity among patients with impaired glucose tolerance in the diabetes prevention program. Diabetes Care 30:2453–2457
36. Soranzo N, Sanna S, Wheeler E, Gieger C, Radke D, Dupuis J, Bouatia-Naji N, Langenberg C, Prokopenko I, Stolerman E, Sandhu MS, Heeney MM, Devaney JM, Reilly MP, Ricketts SL (2010) Common variants at ten genomic loci influence haemoglobin A1C levels via glycemic and non-glycemic pathways. Diabetes 59:3229–3239
37. Cohen RM, Franco RS, Khera PK, Smith EP, Lindsell CJ, Ciraolo PJ, Palascak MB, Joiner CH (2008) Red cell lifespan heterogeneity in haematologically normal people is sufficient to alter HbA1c. Blood 112:4284–4291
38. Hardikar PS, Joshi SM, Bhat DS, Raut DA, Katre PA, Lubree HG, Jere A, Pandit AN, Fall CHD, Yajnik CS (2012) Spuriously high prevalence of prediabetes diagnosed by HbA1c in young Indian partly explained by haematological factors and iron deficiency anemia. Diabetes Care 35:797–802
39. Kim C, Bullard KM, Herman WH, Berckles GL (2010) Association between iron deficiency and A1C levels among adults without diabetes in the National Health and Nutrition Survey, 1999–2006. Diabetes Care 33:780–785